Michelle Xia is a prominent Chinese biopharmaceutical executive, known for co-founding Akeso in 2012. Since its inception, she has held the roles of chairwoman, president, and chief executive officer of the company. Under her leadership, Akeso successfully listed on the Main Board of the Hong Kong Stock Exchange in April 2020.